A study published just two months after the FDA issued a statement acknowledging a late mortality signal with paclitaxel-coated and -eluting stents and balloons suggests the devices are actually safe in patients with lower extremity artery disease.

The Centers for Disease Control and Prevention doubled down on its warnings about vaping products Oct. 3 after new numbers revealed more than 1,000 reports of vaping-related lung illness and 18 fatalities in recent weeks.

Transient endothelial dysfunction stemming from mental duress was associated with a 78% increase in the incidence of MACE in a study of patients with stable CAD, providing scientists with a look at just how much psychological stress can influence our risk of CVD.

A poll conducted by researchers at Fairleigh Dickinson University in New Jersey has revealed that a quarter of Americans take daily low-dose aspirin at some point in their lives, but the majority of those people don’t have heart disease or another chronic illness.

Cardiac radiation dose exposure is a modifiable cardiac risk factor for major cardiac adverse events and all-cause mortality in patients undergoing radiotherapy for non-small-cell lung cancer, researchers report in the Journal of the American Heart Association.

A simplified cardiac risk score can identify plaque buildup and silent brain infarctions that could predict a serious stroke, acting as a red flag for patients without a history of CVD or other vascular problems.

CVS Pharmacy announced Sept. 28 it would be suspending the sales of all Zantac-brand and CVS Health-brand ranitidine products until further notice, pending the results of an FDA investigation.

Tests commissioned by NBC News have revealed that vitamin E—the suspected culprit behind some 800-plus reported cases of vaping-related lung illness—is present in many THC cartridges sold on the black market, alongside other toxicities like pesticides and myclobutanil.